FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384701419> ?p ?o ?g. }

• W4384701419 endingPage "409" @default.
• W4384701419 startingPage "399" @default.
• W4384701419 abstract "The European Societies for Clinical Nutrition and Metabolism (ESPEN) and Blood and Marrow Transplantation (EBMT) recommend enteral nutrition (EN) as the first-choice medical nutrition therapy in acute myeloid leukemia (AML) patients undergoing intensive treatments, including high-dose remission-induction chemotherapy and hematopoietic stem cell transplantation (HSCT). However, parenteral nutrition (PN) remains the preferred method of nutrition support in current clinical practice. The aim of this qualitative study was to gain insight into hematologists' experiences and perspectives regarding the choice and ESPEN/EBMT recommendations on EN versus PN.Online semi-structured interviews were conducted with one hematologist from each of the 21 hospitals offering intensive AML treatments in the Netherlands, using Microsoft Teams. Interviews were audio-recorded, transcribed verbatim and thematically analyzed using Atlas. ti. One hundred nineteen hematologists working in the same hospitals were invited to complete a short online questionnaire survey (SurveyMonkey®) regarding their knowledge and opinion on the ESPEN/EBMT guidelines recommending EN over PN during intensive AML treatments. The results of this survey are presented in a descriptive way.Fifty-nine hematologists participated in this study (42% overall response rate), of which 21 in the semi-structured interviews (response rate 100%) and 38 in the online survey (response rate 32%). Hematologists considered medical nutrition therapy important for prevention and treatment of malnutrition and associated adverse outcomes in AML patients undergoing intensive remission-induction treatment and HSCT. However, opposed to the ESPEN/EBMT guidelines, the vast majority of hematologists were hesitant or reluctant to use EN instead of PN as the first-choice medical nutrition therapy in these patients. The most frequently cited barriers to use EN were the expected low feasibility and tolerance of EN, feeding tube-related discomfort and bleeding risk, and patient refusal. Other barriers to follow the guidelines on EN were related to personal factors, including hematologists' knowledge (lack of awareness and familiarity) and attitude (lack of agreement, outcome expectancy, experience, success, motivation, and learning culture), guideline-related factors (lack of evidence and applicability), and external factors (lack of collaboration and resources). Facilitators included strategies for nutrition education and dissemination of nutritional guidelines, interprofessional and patient collaboration, availability of feeding tubes that can be inserted without endoscopy and stronger scientific evidence.Hematologists recognized the importance of medical nutrition therapy for reducing malnutrition and related negative outcomes during intensive AML treatments. However, contrary to the ESPEN/EBMT guidelines, they preferred PN instead of EN as the medical nutrition therapy of first choice. To reduce compliance barriers, interventions should focus on improving hematologists' knowledge of medical nutrition therapy and dietary guidelines, enhancing success rates of EN by adequately triaging patients eligible for EN and inserting duodenal feeding tubes using an electromagnetic sensing device without endoscopy, developing decision aids and multidisciplinary guidelines and care pathways. Furthermore, future trials should focus on the feasibility and benefits of EN versus PN both during remission-induction treatment and HSCT." @default.
• W4384701419 created "2023-07-20" @default.
• W4384701419 creator A5011411216 @default.
• W4384701419 creator A5014965698 @default.
• W4384701419 creator A5027812561 @default.
• W4384701419 creator A5034779401 @default.
• W4384701419 creator A5039403992 @default.
• W4384701419 creator A5049740797 @default.
• W4384701419 creator A5060657195 @default.
• W4384701419 creator A5066299287 @default.
• W4384701419 creator A5083107291 @default.
• W4384701419 creator A5087468150 @default.
• W4384701419 date "2023-10-01" @default.
• W4384701419 modified "2023-10-17" @default.
• W4384701419 title "Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists’ experiences and perspectives" @default.
• W4384701419 cites W1533887339 @default.
• W4384701419 cites W1546627375 @default.
• W4384701419 cites W1894747421 @default.
• W4384701419 cites W1967935545 @default.
• W4384701419 cites W1977994056 @default.
• W4384701419 cites W1978874371 @default.
• W4384701419 cites W1981453950 @default.
• W4384701419 cites W1981546732 @default.
• W4384701419 cites W1992029894 @default.
• W4384701419 cites W1994307831 @default.
• W4384701419 cites W2004992751 @default.
• W4384701419 cites W2010083182 @default.
• W4384701419 cites W2012827549 @default.
• W4384701419 cites W2024310314 @default.
• W4384701419 cites W2054016027 @default.
• W4384701419 cites W2067652191 @default.
• W4384701419 cites W2073114647 @default.
• W4384701419 cites W2073247149 @default.
• W4384701419 cites W2102254837 @default.
• W4384701419 cites W2124047443 @default.
• W4384701419 cites W2155280990 @default.
• W4384701419 cites W2169730876 @default.
• W4384701419 cites W2313400220 @default.
• W4384701419 cites W2325904558 @default.
• W4384701419 cites W2400122984 @default.
• W4384701419 cites W2416327393 @default.
• W4384701419 cites W2505149831 @default.
• W4384701419 cites W2511686258 @default.
• W4384701419 cites W2519688119 @default.
• W4384701419 cites W2521019952 @default.
• W4384701419 cites W2538095301 @default.
• W4384701419 cites W2568356621 @default.
• W4384701419 cites W2582191635 @default.
• W4384701419 cites W2587825292 @default.
• W4384701419 cites W2611888495 @default.
• W4384701419 cites W2763574648 @default.
• W4384701419 cites W2793237100 @default.
• W4384701419 cites W2793483425 @default.
• W4384701419 cites W2795105152 @default.
• W4384701419 cites W2887252590 @default.
• W4384701419 cites W2889046974 @default.
• W4384701419 cites W2897741688 @default.
• W4384701419 cites W2920549940 @default.
• W4384701419 cites W2940411187 @default.
• W4384701419 cites W2950374023 @default.
• W4384701419 cites W2964001406 @default.
• W4384701419 cites W2980748765 @default.
• W4384701419 cites W2999013197 @default.
• W4384701419 cites W3009366012 @default.
• W4384701419 cites W3012204013 @default.
• W4384701419 cites W3022160085 @default.
• W4384701419 cites W3047580344 @default.
• W4384701419 cites W3082493974 @default.
• W4384701419 cites W3091814354 @default.
• W4384701419 cites W3115108242 @default.
• W4384701419 cites W3132483797 @default.
• W4384701419 cites W3135491477 @default.
• W4384701419 cites W4200370721 @default.
• W4384701419 cites W4200537432 @default.
• W4384701419 cites W4205713095 @default.
• W4384701419 cites W4211216570 @default.
• W4384701419 doi "https://doi.org/10.1016/j.clnesp.2023.07.015" @default.
• W4384701419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37739686" @default.
• W4384701419 hasPublicationYear "2023" @default.
• W4384701419 type Work @default.
• W4384701419 citedByCount "0" @default.
• W4384701419 crossrefType "journal-article" @default.
• W4384701419 hasAuthorship W4384701419A5011411216 @default.
• W4384701419 hasAuthorship W4384701419A5014965698 @default.
• W4384701419 hasAuthorship W4384701419A5027812561 @default.
• W4384701419 hasAuthorship W4384701419A5034779401 @default.
• W4384701419 hasAuthorship W4384701419A5039403992 @default.
• W4384701419 hasAuthorship W4384701419A5049740797 @default.
• W4384701419 hasAuthorship W4384701419A5060657195 @default.
• W4384701419 hasAuthorship W4384701419A5066299287 @default.
• W4384701419 hasAuthorship W4384701419A5083107291 @default.
• W4384701419 hasAuthorship W4384701419A5087468150 @default.
• W4384701419 hasConcept C126322002 @default.
• W4384701419 hasConcept C177713679 @default.
• W4384701419 hasConcept C187212893 @default.
• W4384701419 hasConcept C197934379 @default.
• W4384701419 hasConcept C2777408962 @default.
• W4384701419 hasConcept C2911091166 @default.

• next